AAAAAA

   
Results: 1-16 |
Results: 16
RATIONAL DESIGN OF IRINOTECAN ADMINISTRATION BASED ON PRECLINICAL MODELS
Authors: MINDERMAN H CAO SS RUSTUM YM
Citation: H. Minderman et al., RATIONAL DESIGN OF IRINOTECAN ADMINISTRATION BASED ON PRECLINICAL MODELS, Oncology, 12(8), 1998, pp. 22-30
EVALUATION OF TOPOISOMERASE-I CATALYTIC ACTIVITY AS DETERMINANT OF DRUG RESPONSE IN HUMAN CANCER CELL-LINES
Authors: VOIGT W VANHOEFER U YIN MB MINDERMAN H SCHMOLL HJ RUSTUM YM
Citation: W. Voigt et al., EVALUATION OF TOPOISOMERASE-I CATALYTIC ACTIVITY AS DETERMINANT OF DRUG RESPONSE IN HUMAN CANCER CELL-LINES, Anticancer research, 17(5A), 1997, pp. 3707-3711
FREQUENT COEXISTENCE OF MULTIPLE MECHANISMS OF MULTIDRUG-RESISTANCE IN ACUTE MYELOID-LEUKEMIA CELLS
Authors: BAER MR SWANN VL STROLLO NM CARVER AJ MINDERMAN H RUSTUM Y STEWART CC
Citation: Mr. Baer et al., FREQUENT COEXISTENCE OF MULTIPLE MECHANISMS OF MULTIDRUG-RESISTANCE IN ACUTE MYELOID-LEUKEMIA CELLS, Blood, 90(10), 1997, pp. 802-802
PAK-104P, A PYRIDINE ANALOG, REVERSES PACLITAXEL AND DOXORUBICIN RESISTANCE IN CELL-LINES AND NUDE-MICE BEARING XENOGRAFTS THAT OVEREXPRESSTHE MULTIDRUG-RESISTANCE PROTEIN
Authors: VANHOEFER U CAO SR MINDERMAN H TOTH K SCHEPER RJ SLOVAK ML RUSTUM YM
Citation: U. Vanhoefer et al., PAK-104P, A PYRIDINE ANALOG, REVERSES PACLITAXEL AND DOXORUBICIN RESISTANCE IN CELL-LINES AND NUDE-MICE BEARING XENOGRAFTS THAT OVEREXPRESSTHE MULTIDRUG-RESISTANCE PROTEIN, Clinical cancer research, 2(2), 1996, pp. 369-377
D,L-BUTHIONINE-(S,R)-SULFOXIMINE POTENTIATES IN-VIVO THE THERAPEUTIC EFFICACY OF DOXORUBICIN AGAINST MULTIDRUG-RESISTANCE PROTEIN-EXPRESSING TUMORS
Authors: VANHOEFER U CAO SS MINDERMAN H TOTH K SKENDERIS BS SLOVAK ML RUSTUM YM
Citation: U. Vanhoefer et al., D,L-BUTHIONINE-(S,R)-SULFOXIMINE POTENTIATES IN-VIVO THE THERAPEUTIC EFFICACY OF DOXORUBICIN AGAINST MULTIDRUG-RESISTANCE PROTEIN-EXPRESSING TUMORS, Clinical cancer research, 2(12), 1996, pp. 1961-1968
DIOC(2)(3) IS NOT A SUBSTRATE FOR MULTIDRUG-RESISTANCE PROTEIN (MRP)-MEDIATED DRUG EFFLUX
Authors: MINDERMAN H VANHOEFER U TOTH K YIN MB MINDERMAN MD WRZOSEK C SLOVAK ML RUSTUM YM
Citation: H. Minderman et al., DIOC(2)(3) IS NOT A SUBSTRATE FOR MULTIDRUG-RESISTANCE PROTEIN (MRP)-MEDIATED DRUG EFFLUX, Cytometry, 25(1), 1996, pp. 14-20
A UNIQUE HUMAN OVARIAN-CARCINOMA CELL-LINE EXPRESSING CD34 IN ASSOCIATION WITH SELECTION FOR MULTIDRUG-RESISTANCE
Authors: MINDERMAN H VANHOEFER U TOTH K MINDERMAN MD RUSTUM YM
Citation: H. Minderman et al., A UNIQUE HUMAN OVARIAN-CARCINOMA CELL-LINE EXPRESSING CD34 IN ASSOCIATION WITH SELECTION FOR MULTIDRUG-RESISTANCE, Cancer, 78(11), 1996, pp. 2427-2436
BIOLOGICAL EFFECTS OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH UNTREATED ACUTE MYELOID-LEUKEMIA
Authors: BAER MR BERNSTEIN SH BRUNETTO VL HEINONEN K MROZEK K SWANN VL MINDERMAN H BLOCK AW PIXLEY LA CHRISTIANSEN NP FAY JW BARCOS M RUSTUM Y HERZIG GP BLOOMFIELD CD
Citation: Mr. Baer et al., BIOLOGICAL EFFECTS OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH UNTREATED ACUTE MYELOID-LEUKEMIA, Blood, 87(4), 1996, pp. 1484-1494
DETECTION OF INCORPORATED IODODEOXYURIDINE IN COLONIES BY IMMUNOPEROXIDASE STAINING - A NOVEL METHOD TO MEASURE THE PROPORTION OF CYCLING COLONY-FORMING CELLS
Authors: VANDERLELY N MINDERMAN H WESSELS H HILLEGERS M LINSSEN P PENNINGS A BRONS P BOEZEMAN J DEWITTE T
Citation: N. Vanderlely et al., DETECTION OF INCORPORATED IODODEOXYURIDINE IN COLONIES BY IMMUNOPEROXIDASE STAINING - A NOVEL METHOD TO MEASURE THE PROPORTION OF CYCLING COLONY-FORMING CELLS, Experimental hematology, 23(3), 1995, pp. 236-243
SCHEDULE-DEPENDENT EFFICACY OF IDARUBICIN (IDA) AND DOXORUBICIN (DOX)
Authors: MINDERMAN H BUSCAGLIA MD RUSTUM YM
Citation: H. Minderman et al., SCHEDULE-DEPENDENT EFFICACY OF IDARUBICIN (IDA) AND DOXORUBICIN (DOX), Leukemia, 8(8), 1994, pp. 1401-1405
TOXICITY OF IDARUBICIN AND DOXORUBICIN TOWARDS NORMAL AND LEUKEMIC HUMAN BONE-MARROW PROGENITORS IN RELATION TO THEIR PROLIFERATIVE STATE
Authors: MINDERMAN H LINSSEN P VANDERLELY N WESSELS J BOEZEMAN J DEWITTE T HAANEN C
Citation: H. Minderman et al., TOXICITY OF IDARUBICIN AND DOXORUBICIN TOWARDS NORMAL AND LEUKEMIC HUMAN BONE-MARROW PROGENITORS IN RELATION TO THEIR PROLIFERATIVE STATE, Leukemia, 8(3), 1994, pp. 382-387
EFFECT OF DOXORUBICIN, DAUNORUBICIN, AND IDARUBICIN ON THE GROWTH-RATE OF HUMAN LEUKEMIA-CELLS (K562) STUDIED WITH IMAGE-ANALYSIS
Authors: MINDERMAN H SLOCUM HK MALMBERG M HAANEN C RUSTUM YCM
Citation: H. Minderman et al., EFFECT OF DOXORUBICIN, DAUNORUBICIN, AND IDARUBICIN ON THE GROWTH-RATE OF HUMAN LEUKEMIA-CELLS (K562) STUDIED WITH IMAGE-ANALYSIS, Leukemia, 7(6), 1993, pp. 872-877
CHARACTERIZATION OF TUMOR-CELL HETEROGENEITY OF A MURINE LEUKEMIA-CELL LINE (L1210) IN RESPONSE TO ARABINOSYLCYTOSINE - QUANTITATION USING A COMPUTERIZED IMAGE-ANALYSIS SYSTEM
Authors: RAYMAKERS RAP SLOCUM HK MINDERMAN H MALMBERG M RUSTUM YM
Citation: Rap. Raymakers et al., CHARACTERIZATION OF TUMOR-CELL HETEROGENEITY OF A MURINE LEUKEMIA-CELL LINE (L1210) IN RESPONSE TO ARABINOSYLCYTOSINE - QUANTITATION USING A COMPUTERIZED IMAGE-ANALYSIS SYSTEM, Experimental hematology, 21(5), 1993, pp. 602-607
CELL-CYCLE RELATED UPTAKE, RETENTION AND TOXICITY OF IDARUBICIN, DAUNORUBICIN AND DOXORUBICIN
Authors: MINDERMAN H LINSSEN P WESSELS J HAANEN C
Citation: H. Minderman et al., CELL-CYCLE RELATED UPTAKE, RETENTION AND TOXICITY OF IDARUBICIN, DAUNORUBICIN AND DOXORUBICIN, Anticancer research, 13(4), 1993, pp. 1161-1165
IDARUBICIN-RELATED SIDE-EFFECTS IN RECIPIENTS OF T-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTS ARE SCHEDULE-DEPENDENT
Authors: MUUS P DONNELLY P SCHATTENBERG A LINSSEN P MINDERMAN H DOMPELING E DEWITTE T
Citation: P. Muus et al., IDARUBICIN-RELATED SIDE-EFFECTS IN RECIPIENTS OF T-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTS ARE SCHEDULE-DEPENDENT, Seminars in oncology, 20(6), 1993, pp. 47-52
IN-VIVO RECOMBINANT HUMAN G-CSF PRIMING IN PREVIOUSLY UNTREATED ACUTEMYELOID-LEUKEMIA
Authors: BAER MR BERNSTEIN SH BRUNETTO VL MINDERMAN H RUSTUM Y BLOCK AW MROZEK K BLOOMFIELD CD HERZIG GP
Citation: Mr. Baer et al., IN-VIVO RECOMBINANT HUMAN G-CSF PRIMING IN PREVIOUSLY UNTREATED ACUTEMYELOID-LEUKEMIA, Blood, 82(10), 1993, pp. 10000328-10000328
Risultati: 1-16 |